Abbott Laboratories Gross Profit 2010-2025 | ABT
Abbott Laboratories annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Abbott Laboratories gross profit for the quarter ending March 31, 2025 was $5.890B, a 7.07% increase year-over-year.
- Abbott Laboratories gross profit for the twelve months ending March 31, 2025 was $23.633B, a 6.36% increase year-over-year.
- Abbott Laboratories annual gross profit for 2024 was $23.244B, a 5.01% increase from 2023.
- Abbott Laboratories annual gross profit for 2023 was $22.134B, a 9.7% decline from 2022.
- Abbott Laboratories annual gross profit for 2022 was $24.511B, a 0.11% decline from 2021.
| Abbott Laboratories Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $23,244 |
| 2023 | $22,134 |
| 2022 | $24,511 |
| 2021 | $24,538 |
| 2020 | $19,605 |
| 2019 | $18,673 |
| 2018 | $17,872 |
| 2017 | $14,981 |
| 2016 | $11,759 |
| 2015 | $11,658 |
| 2014 | $11,029 |
| 2013 | $10,464 |
| 2012 | $10,151 |
| 2011 | $11,390 |
| 2010 | $20,502 |
| 2009 | $17,555 |
| Abbott Laboratories Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $5,890 |
| 2024-12-31 | $6,032 |
| 2024-09-30 | $5,937 |
| 2024-06-30 | $5,774 |
| 2024-03-31 | $5,501 |
| 2023-12-31 | $5,685 |
| 2023-09-30 | $5,538 |
| 2023-06-30 | $5,495 |
| 2023-03-31 | $5,416 |
| 2022-12-31 | $5,498 |
| 2022-09-30 | $5,781 |
| 2022-06-30 | $6,324 |
| 2022-03-31 | $6,908 |
| 2021-12-31 | $6,702 |
| 2021-09-30 | $6,505 |
| 2021-06-30 | $5,276 |
| 2021-03-31 | $6,055 |
| 2020-12-31 | $6,208 |
| 2020-09-30 | $4,887 |
| 2020-06-30 | $4,065 |
| 2020-03-31 | $4,445 |
| 2019-12-31 | $4,880 |
| 2019-09-30 | $4,718 |
| 2019-06-30 | $4,700 |
| 2019-03-31 | $4,375 |
| 2018-12-31 | $4,574 |
| 2018-09-30 | $4,490 |
| 2018-06-30 | $4,485 |
| 2018-03-31 | $4,323 |
| 2017-12-31 | $4,307 |
| 2017-09-30 | $3,953 |
| 2017-06-30 | $3,448 |
| 2017-03-31 | $3,273 |
| 2016-12-31 | $2,951 |
| 2016-09-30 | $3,017 |
| 2016-06-30 | $3,046 |
| 2016-03-31 | $2,745 |
| 2015-12-31 | $2,982 |
| 2015-09-30 | $2,908 |
| 2015-06-30 | $2,952 |
| 2015-03-31 | $2,816 |
| 2014-12-31 | $3,019 |
| 2014-09-30 | $2,760 |
| 2014-06-30 | $2,769 |
| 2014-03-31 | $2,481 |
| 2013-12-31 | $2,047 |
| 2013-09-30 | $2,570 |
| 2013-06-30 | $2,901 |
| 2013-03-31 | $2,946 |
| 2012-12-31 | $1,507 |
| 2012-09-30 | $2,776 |
| 2012-06-30 | $2,943 |
| 2012-03-31 | $2,925 |
| 2011-12-31 | $6,539 |
| 2011-09-30 | $5,843 |
| 2011-06-30 | $5,746 |
| 2011-03-31 | $5,182 |
| 2010-12-31 | $5,923 |
| 2010-09-30 | $4,933 |
| 2010-06-30 | $5,282 |
| 2010-03-31 | $4,363 |
| 2009-12-31 | $5,006 |
| 2009-09-30 | $4,401 |
| 2009-06-30 | $4,366 |
| 2009-03-31 | $3,782 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $222.716B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $157.517B | 37.62 |
| Stryker (SYK) | United States | $152.893B | 31.97 |
| EssilorLuxottica (ESLOY) | France | $140.240B | 0.00 |
| Medtronic (MDT) | Ireland | $118.558B | 16.81 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.586B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.070B | 25.15 |
| ResMed (RMD) | United States | $40.718B | 30.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.587B | 16.90 |
| Agilent Technologies (A) | United States | $34.042B | 22.19 |
| Koninklijke Philips (PHG) | Netherlands | $26.981B | 17.85 |
| Terumo (TRUMY) | Japan | $25.673B | 33.35 |
| Insulet (PODD) | United States | $20.514B | 80.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.786B | 12.06 |
| Baxter (BAX) | United States | $14.800B | 11.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.840B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.874B | 23.92 |
| Lantheus Holdings (LNTH) | United States | $4.995B | 12.60 |
| Perrigo (PRGO) | Ireland | $3.859B | 9.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.689B | 16.48 |
| Haemonetics (HAE) | United States | $3.629B | 16.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.441B | 28.59 |
| ICU Medical (ICUI) | United States | $3.119B | 23.00 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.64 |
| QuidelOrtho (QDEL) | United States | $1.720B | 11.83 |
| AtriCure (ATRC) | United States | $1.571B | 0.00 |
| Acuren (TIC) | United States | $1.369B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.272B | 28.62 |
| AdaptHealth (AHCO) | United States | $1.259B | 12.78 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.057B | 0.00 |
| Neogen (NEOG) | United States | $1.048B | 16.66 |
| Curaleaf Holdings (CURLF) | Canada | $0.933B | 0.00 |
| InMode (INMD) | Israel | $0.905B | 9.11 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Valneva SE (VALN) | France | $0.660B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.632B | 0.00 |
| Evolus (EOLS) | United States | $0.596B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.581B | 0.00 |
| Owens & Minor (OMI) | United States | $0.576B | 4.78 |
| Surmodics (SRDX) | United States | $0.535B | 0.00 |
| CeriBell (CBLL) | United States | $0.533B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.81 |
| SNDL (SNDL) | Canada | $0.384B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.322B | 11.83 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.308B | 0.00 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.298B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.295B | 0.00 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 74.00 |
| Biote (BTMD) | United States | $0.249B | 7.00 |
| Viemed Healthcare (VMD) | United States | $0.247B | 20.87 |
| Omeros (OMER) | United States | $0.245B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.245B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.15 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.217B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.09 |
| Exagen (XGN) | United States | $0.180B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.177B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.18 |
| Jushi Holdings (JUSHF) | United States | $0.107B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.74 |
| Quipt Home Medical (QIPT) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.081B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| Apyx Medical (APYX) | United States | $0.074B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.064B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.92 |
| Nephros (NEPH) | United States | $0.037B | 49.57 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |